Nanjing Leads Biolabs Co., Ltd. ('Leads Biolabs') today announced the presentation of groundbreaking clinical data from a multicenter phase Ib/II clinical trial evaluating LBL-024, an anti-PD-L1/4-1BB ...

The smartphone-sized, battery-powered test is a cost-effective tool that can improve TB diagnoses, particularly in rural ...